A 57-year-old man with Type-2 diabetes presents to the primary care clinic for follow-up. He has been taking metformin and has had good control of his sugars. He denies any hypoglycemic episodes or peripheral neuropathy. His hemoglobin \A_{1c is 8.3%, which is increased from 7.9% previously. The physician decides to add miglitol to his regimen. What is the mechanism of action of miglitol?

A 57-year-old man with Type-2 diabetes presents to the primary care clinic for follow-up. He has been taking metformin and has had good control of his sugars. He denies any hypoglycemic episodes or peripheral neuropathy. His hemoglobin \A_{1c is 8.3%, which is increased from 7.9% previously. The physician decides to add miglitol to his regimen. What is the mechanism of action of miglitol?

Regarding the biosynthesis of thyroid hormones, if a novel medication was developed to block the proteolytic release of hormones, this medication would act at which of the following sites?

A 55-year-old man presents to his primary care physician to follow up on his hyperlipidemia medication. Lab work suggests that his total cholesterol, LDL, triglycerides, and HDL are all within normal limits because of the lovastatin he began taking 2 months ago. He has not visited the office since being prescribed this medication. Which of the following lab tests should be obtained at the present office visit?

A patient presents with lethargy, tiredness, cold intolerance, dryness of skin and hair, hoarsness of voice and weight gain. He also has psychosis and his heart rate appears to be lower than normal. Which of the following is not associated with the presenting symptoms?

A patient presents with tiredness, weakness, anorexia, apathy, abdominal pain, hyperpigmentation and postural hypertension. Upon infection he appears to be in cardiogenic shock and his blood volume is depleted. His sodium levels are low, potassium levels are high. Which of the following would also be elevated?